We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Microfluidic Blood-Cleansing Device Battles Sepsis

By HospiMedica International staff writers
Posted on 05 Oct 2014
Print article
Image: The biospleen blood-cleansing device (Photo courtesy of the Wyss Institute/ Harvard).
Image: The biospleen blood-cleansing device (Photo courtesy of the Wyss Institute/ Harvard).
A dialysis-like therapeutic device inspired by the human spleen that filters bacteria, fungi, and toxins could radically transform the way doctors treat sepsis.

The biospleen device, developed by researchers at Harvard University (Boston, MA, USA), is a microfluidic filter that consists of two adjacent hollow channels connected to each other by a series of slits: one channel contains flowing blood, and the other contains a saline solution. The key to the device are tiny nanometer-sized magnetic beads coated with a genetically engineered hybrid version of a natural immune system protein called opsonin-mannose-binding lectin (MBL).

The researchers attached the hybrid proteins to magnetic beads (128 nanometers in diameter) that could be added to blood of an infected patient to bind to the pathogens and toxins, without having to first identify the type of infectious agent. A magnet then pulls the pathogen-coated magnetic beads through the channels to cleanse the blood flowing through the device, which is returned to the patient. The researchers decided to first test the system in vitro, using human blood spiked with pathogens.

They found that the device efficiently removed multiple Gram-negative bacteria, Gram-positive bacteria, fungi, and endotoxins from whole human blood flowing through a single biospleen unit at up to 1.25 liters/hour; in principal, many devices could be linked together to cleanse human blood at dialysis-like rates. They also tested the device using rats infected with E. coli, S. aureus, and toxins. Similar to the tests on human blood, and after just five hours of filtering, about 90% of the bacteria and toxin were removed from the rats' bloodstream. The study describing the biospleen device was published on September 14, 2104, in Nature Medicine.

“Sepsis is a major medical threat, which is increasing because of antibiotic resistance. We're excited by the biospleen because it potentially provides a way to treat patients quickly without having to wait days to identify the source of infection, and it works equally well with antibiotic-resistant organisms,” said senior author Prof. Donald Ingber, MD, PhD, founding director of the Harvard Wyss Institute for Biologically Inspired Engineering. “We hope to move this towards human testing to advancing to large animal studies as quickly as possible.”

Sepsis, which causes millions of deaths globally each year, is characterized by an inflammatory state resulting from the immune system's response to a serious infection triggered by bacteria, fungi, viruses, and parasites in the blood, urinary tract, lungs, skin, or other tissues. Common symptoms of sepsis include those related to a specific infection, but are usually accompanied by high fevers, hot, flushed skin, elevated heart rate, hyperventilation, altered mental status, swelling, and low blood pressure.

Related Links:

Harvard University
Wyss Institute for Biologically Inspired Engineering


Gold Supplier
Enteral Feeding Pump
SENTINELplus
New
Capnograph/Pulse Oximeter
Handleld Capnograph/Pulse Oximeter
New
Portable Manual Defibrillator
RESCUE 230
New
Elevating X-Ray Table
PROGNOST F

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Surgical Techniques

view channel
Image: Gut microbiota helps healing in colorectal cancer surgery (Photo courtesy of CRCHUM)

Modifying Intestinal Flora Before Surgery Reduces Postoperative Complications in Colorectal Cancer Patients

Up to 30% of all patients undergoing colorectal surgery suffer from serious complications due to poor healing of their intestinal barrier. Anastomotic complications cause inflammation, serious infection... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.